3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
143
Observational
2
Sponsor
Cancer Type
Breast
2
Conditions
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
6
Ovarian Neoplasms
5
Small Cell Lung Carcinoma
4
Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Recurrence
1
Pancreatic Neoplasms
1
PROMs
1
Ototoxicity
1
Neurotoxicity Syndromes
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Hearing Loss
1
Fatigue
1
Fallopian Tube Neoplasms
1
Eunuchism
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Chemotherapy-induced Peripheral Neuropathy
1
Central Nervous System Neoplasms
1
Interventions
Blood Specimen Collection
5
Drug Therapy
3
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Carboplatin
2
Biopsy, Large-Core Needle
2
Biopsy
2
toripalimab
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
atezolizumab
1
Zoledronic Acid
1
Urine Specimen Collection
1
Prophylactic Mastectomy
1
Paracentesis
1
Neuropsychological Tests
1
Mifepristone
1
Medicine, Chinese Traditional
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Doxorubicin
1
DNA
1
Cyclophosphamide
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Carboplatin
×
Clear all
NCT06965361
2025-05-16
TIL; PD1; PDL1
Ziauddin University
Completed
54 enrolled
NCT05916755
2023-06-23
PORTRAIT
Vall d'Hebron Institute of Oncology
Recruiting
100 enrolled